Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Research area

Phase 1 Melanoma trials

Melanoma is a form of skin cancer, and research into it examines investigational immunotherapies, targeted medications, and combinations. If you are looking into a study for yourself or for a person in your care, we at Phase 1 Cancer Trials can help work out if one might be suitable.

Updated

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Phase 1 melanoma studies in numbers

Phase 1 melanoma studies recruiting in the U.S.
106
states with a study site
32
studies that accept healthy volunteers
1

Source: ClinicalTrials.gov. Data processed .

Find Phase 1 melanoma studies by state

These states have the most studies recruiting right now.

Phase 1 melanoma studies recruiting now

As of November 17, 2026, 106 Phase 1 melanoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.

What they test

  • medications81
  • biologics such as vaccines or antibodies38
  • procedures9
  • devices5
  • combination products3

A study can test more than one.

Main purpose

  • treating a condition102
  • supportive care2
  • diagnosis1
  • other purposes1

Phase

  • Early Phase 15
  • Phase 149
  • Phase 1/252

Who runs them

  • industry61
  • university, hospital or other42
  • government3

Who they enroll

  • adults (18 to 64)105
  • older adults (65 and over)101
  • children (under 18)6

1 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 106 studies.

Recently updated Phase 1 melanoma studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora, CO · Boston, MA · Chicago, IL · and 4 more U.S. locations
    Registry record
    NCT02332668 · updated
  2. A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Outpace Bio, Inc.
    Recruiting in
    Atlanta, GA · Detroit, MI · Houston, TX · and 2 more U.S. locations
    Registry record
    NCT07664735 · updated
  3. Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)

    • Phase 1
    • Ages 3 to 25
    • All sexes
    Sponsor
    Children's National Research Institute
    Recruiting in
    Washington D.C., DC
    Registry record
    NCT07796061 · updated
  4. A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Recruiting in
    Durham, NC
    Registry record
    NCT05077137 · updated
  5. IL-17 Blockade to Decrease irAEs (REPLAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Recruiting in
    Durham, NC
    Registry record
    NCT07237594 · updated
  6. A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Relay Therapeutics, Inc.
    Recruiting in
    Aurora, CO · Boston, MA · Fairfax, VA · and 5 more U.S. locations
    Registry record
    NCT07584226 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in the United States on ClinicalTrials.gov.

What melanoma studies look at

Melanoma is a form of skin cancer. Studies in this area examine immunotherapies, targeted medications, and combinations, all of them investigational. A study is designed to answer one particular question, so what a melanoma trial asks of you changes from one study to the next.

When something is under test in a study, we call it investigational. Researchers do not yet have the full picture of its risks or of how well it works. The study exists to build that picture.

Who may be able to take part

Requirements are set study by study. Your age may count. So may the medications you currently take, your past health, and the effect the cancer has on you. There are also studies that enroll people without the condition.

Working out eligibility is not your job. During a screening visit, the study team does the checking for you. Our guide explains how screening and eligibility work.

What taking part usually involves

  1. A first conversation

    The first step in a Phase 1 melanoma trial is hearing about it. A study coordinator describes the trial in general terms and answers what you ask. That comes ahead of everything else.

  2. Informed consent

    The study team writes out the complete details for you, known risks among them. Whether you agree is yours to decide.

  3. Screening

    Screening is a set of tests and questions about your health. The results tell you and the team if the study is suitable. Being screened does not always lead to taking part.

  4. Study visits

    Joining a Phase 1 melanoma trial means coming in for scheduled appointments. The study team uses each one to follow how your health is doing. Leaving is your choice, and you can make it at any point in the study.

Questions about Phase 1 melanoma studies

Do I need a diagnosis to join a study about melanoma?

There is no single answer, because studies differ. A confirmed diagnosis is asked for in some. In others, the assessment is done during screening. Which of these applies is something the study team will explain to you.

Would I have to change the care I receive now?

No part of your care should be altered by you alone. Continuing current care is permitted in certain studies and not permitted in others. This is something the study doctor will review with you. Your own doctor can talk it through with you too, ahead of any decision.

Is there a cost to take part?

As a rule, there is no cost to participants for the study medication, the study tests, or the study visits. You can learn more about costs in our participant guide.

Ask about Phase 1 melanoma studies

It takes a few details from you, and then a coordinator gets in touch. Asking about a Phase 1 cancer trial places you under no obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call